Sartorius Stedim Biotech S.A. total revenue, net income and dynamics of changes in Euro today
Sartorius Stedim Biotech S.A. current income in Euro. Net revenue of Sartorius Stedim Biotech S.A. on 30/06/2021 amounted to 696 700 000 €. Net income Sartorius Stedim Biotech S.A. - 144 200 000 €. Information about net income is used from open sources. Schedule of the financial report of Sartorius Stedim Biotech S.A. for today. Information on Sartorius Stedim Biotech S.A. net income on the chart on this page is drawn in blue bars. A graph of the value of all Sartorius Stedim Biotech S.A. assets is presented in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Dates of Sartorius Stedim Biotech S.A. finance reports: 31/03/2019, 31/03/2021, 30/06/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of Sartorius Stedim Biotech S.A. is 30/06/2021. Gross profit Sartorius Stedim Biotech S.A. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Sartorius Stedim Biotech S.A. is 384 300 000 €
Cost of revenue Sartorius Stedim Biotech S.A. is the total cost of producing and distributing of products and services of a company. Cost of revenue Sartorius Stedim Biotech S.A. is 312 400 000 € Total revenue Sartorius Stedim Biotech S.A. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Sartorius Stedim Biotech S.A. is 696 700 000 € Operating income Sartorius Stedim Biotech S.A. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Sartorius Stedim Biotech S.A. is 216 900 000 €
Net income Sartorius Stedim Biotech S.A. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Sartorius Stedim Biotech S.A. is 144 200 000 € Current assets Sartorius Stedim Biotech S.A. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Sartorius Stedim Biotech S.A. is 1 252 000 000 € Total assets Sartorius Stedim Biotech S.A. refers to the total amount of assets owned by a person or entity. Total assets Sartorius Stedim Biotech S.A. is 3 521 900 000 €
30/06/2021
31/03/2021
31/12/2020
30/09/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
384 300 000 €
351 800 000 €
269 830 000 €
276 000 000 €
190 846 000 €
191 600 000 €
188 600 000 €
177 300 000 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
312 400 000 €
303 400 000 €
260 851 000 €
234 400 000 €
173 024 000 €
175 800 000 €
177 800 000 €
165 600 000 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
696 700 000 €
655 200 000 €
530 681 000 €
510 400 000 €
363 870 000 €
367 400 000 €
366 400 000 €
342 900 000 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
363 870 000 €
367 400 000 €
366 400 000 €
342 900 000 €
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
216 900 000 €
197 500 000 €
150 340 000 €
145 800 000 €
97 038 000 €
83 800 000 €
87 100 000 €
80 000 000 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
144 200 000 €
114 500 000 €
114 249 000 €
101 500 000 €
55 074 000 €
58 500 000 €
64 800 000 €
56 100 000 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
27 600 000 €
24 700 000 €
23 851 000 €
22 000 000 €
23 416 000 €
19 100 000 €
19 000 000 €
17 700 000 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
479 800 000 €
457 700 000 €
380 341 000 €
364 600 000 €
266 832 000 €
283 600 000 €
279 300 000 €
262 900 000 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
1 252 000 000 €
1 061 800 000 €
875 216 000 €
961 100 000 €
633 802 000 €
652 700 000 €
609 100 000 €
587 200 000 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
3 521 900 000 €
3 313 000 000 €
3 069 336 000 €
2 361 500 000 €
1 820 421 000 €
1 771 800 000 €
1 693 800 000 €
1 660 400 000 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
254 700 000 €
149 400 000 €
59 762 000 €
165 900 000 €
27 643 000 €
35 000 000 €
25 500 000 €
25 800 000 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
427 345 000 €
424 800 000 €
416 200 000 €
436 900 000 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
642 792 000 €
595 300 000 €
586 700 000 €
604 700 000 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
35.31 %
33.60 %
34.64 %
36.42 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
1 668 500 000 €
1 530 900 000 €
1 460 041 000 €
1 347 200 000 €
1 158 789 000 €
1 167 800 000 €
1 099 100 000 €
1 046 800 000 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
86 229 000 €
83 900 000 €
59 200 000 €
80 800 000 €
Last revenue report of Sartorius Stedim Biotech S.A. was 30/06/2021. According to last financial report total revenue in Sartorius Stedim Biotech S.A. was 696 700 000 Euro and changed by +90.15% since last year. Net income in Sartorius Stedim Biotech S.A. was 144 200 000 € in last quartal, net income changes to +122.53%.
Current cash Sartorius Stedim Biotech S.A. - the sum of all of the cash a company has on the date of report. Current cash Sartorius Stedim Biotech S.A. is 254 700 000 €
